National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...
Medtronic reached a critical juncture last month in its quest to build the market for renal denervation, a new device-based ...
The hope is that renal denervation will solve not only hypertension-related complications but also the various problems associated with antihypertensive drugs that have a negative impact on quality of ...
Twelve specialty societies, including the American Society of Anesthesiologists and others whose members include pain physicians, have joined together to maintain coverage for facet joint injection ...
Credit: Recor Medical. The approval was based on data from the RADIANCE II trial which included patient with mild to moderate hypertension who were adequately controlled with medications. The Food and ...
On Monday, the Centers for Medicare & Medicaid Services (CMS) initiated a national coverage analysis of renal denervation for the treatment of uncontrolled hypertension. Medtronic, which sparked the ...
At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for Medicare ...
BOSTON, MA—Ultrasound-based renal denervation with the Paradise system (ReCor Medical) significantly reduces blood pressure in patients with uncontrolled hypertension who are not on antihypertensive ...
The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...
The US Food and Drug Administration (FDA) has approved the Paradise Ultrasound Renal Denervation system for the treatment of hypertension, Recor Medical Inc and parent company Otsuka Medical Devices ...
It’s game on in the field of renal denervation, with Medtronic claiming the second FDA green light this month for a procedure to treat drug-resistant high blood pressure—a market its developers expect ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results